Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
基本信息
- 批准号:7466758
- 负责人:
- 金额:$ 53.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsAttenuatedBase SequenceBiological ModelsCapsidChimera organismClassCodeCodon NucleotidesComputersCultured CellsData AnalysesDevelopmentDinucleoside PhosphatesEngineeringGenerationsGeneticGenomeGoalsHumanHuman poliovirusImmune responseIn VitroInfluenzaInfluenza A virusMedicalMethodsModelingModificationMolecularMusNucleic AcidsNucleic acid sequencingNumbersOligonucleotidesPoliomyelitisPoliovirusesProteinsPublic HealthRNARNA StabilityScanningScreening procedureSoftware DesignStructureSystemTestingTranslationsVaccinationVaccinesVariantViralViral GenomeViral PhysiologyViral VaccinesVirionVirulenceVirusVirus Diseasesattenuationbasedesignexperiencefitnessinfluenzavirusnovelnovel vaccinesrapid techniquevaccine development
项目摘要
DESCRIPTION (provided by applicant): Using modern methods for synthesizing long DNAs, and using computer algorithms, we have recently synthesized several totally novel variants of polio virus in vitro from oligonucleotides, and we have converted these nucleic acids into infectious virus. These viruses preserve the exact protein coding capacity of wild- type polio, but use synonymous codons in various ways to target translation. Two of the viruses were designed to have poor codon bias, or poor codon pair bias, respectively, and both of these viruses were inviable (i.e., cannot form plaques on cultured cells). Here, we seek to understand exactly why the altered viruses are attenuated; to find ways of generating still other, novel polio viruses attenuated to predictable extents; and to extend this approach of synthesizing predictably-attenuated viruses to other classes of viruses. The most important longer term implication of these studies is that the predictable synthesis of attenuated virus should provide a rapid, safe, inexpensive, general and reliable method of creating the raw material for viral vaccines. In principle, vaccines could be created quickly even for very poorly characterized viruses, as long as a nucleic acid sequence is available.
PUBLIC HEALTH RELEVANCE: Vaccination has been humankind's main most robust defense against viral disease. We describe an entirely novel and rapid method to generate anti-virus vaccine candidates that might prove applicable to most if not all human pathogenic viral systems.
描述(由申请人提供):利用合成长dna的现代方法,并使用计算机算法,我们最近在体外从寡核苷酸合成了几种全新的脊髓灰质炎病毒变体,并将这些核酸转化为传染性病毒。这些病毒保留了野生型脊髓灰质炎的确切蛋白质编码能力,但以不同的方式使用同义密码子来靶向翻译。其中两种病毒分别被设计为具有差密码子偏倚或差密码子对偏倚,这两种病毒都是不可活的(即,不能在培养细胞上形成斑块)。在这里,我们试图确切地理解为什么改变的病毒是减毒的;找到制造其他新型脊髓灰质炎病毒的方法,这些病毒被减弱到可预测的程度;并将这种合成可预测减毒病毒的方法扩展到其他类型的病毒。这些研究最重要的长期意义是,可预测的减毒病毒合成方法应提供一种快速、安全、廉价、通用和可靠的方法来制造病毒疫苗的原料。原则上,只要有核酸序列,即使是针对特征非常差的病毒,也可以快速研制出疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eckard Wimmer其他文献
Eckard Wimmer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eckard Wimmer', 18)}}的其他基金
Tailoring virulence of dengue virus in mammals and mosquitoes
调整登革热病毒对哺乳动物和蚊子的毒力
- 批准号:
9252366 - 财政年份:2015
- 资助金额:
$ 53.17万 - 项目类别:
Tailoring virulence of dengue virus in mammals and mosquitoes
调整登革热病毒对哺乳动物和蚊子的毒力
- 批准号:
9045553 - 财政年份:2015
- 资助金额:
$ 53.17万 - 项目类别:
Tailoring virulence of dengue virus in mammals and mosquitoes
调整登革热病毒对哺乳动物和蚊子的毒力
- 批准号:
8818899 - 财政年份:2015
- 资助金额:
$ 53.17万 - 项目类别:
Rational Design of Live Attenuated Influenza A Vaccine Candidates
甲型流感减毒活疫苗候选物的合理设计
- 批准号:
8490298 - 财政年份:2012
- 资助金额:
$ 53.17万 - 项目类别:
Rational Design of Live Attenuated Influenza A Vaccine Candidates
甲型流感减毒活疫苗候选物的合理设计
- 批准号:
8314931 - 财政年份:2012
- 资助金额:
$ 53.17万 - 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
- 批准号:
8048029 - 财政年份:2008
- 资助金额:
$ 53.17万 - 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
- 批准号:
7591176 - 财政年份:2008
- 资助金额:
$ 53.17万 - 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
- 批准号:
8238127 - 财政年份:2008
- 资助金额:
$ 53.17万 - 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
- 批准号:
7780320 - 财政年份:2008
- 资助金额:
$ 53.17万 - 项目类别:
EUROPIC america 2002: a conference for picornaviruses
EUROPIC america 2002:小核糖核酸病毒会议
- 批准号:
6458806 - 财政年份:2002
- 资助金额:
$ 53.17万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 53.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 53.17万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 53.17万 - 项目类别:
Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 53.17万 - 项目类别:
Research Grant